CRP and COVID-19: We initially investigated the link between lung abnormality persistence by CT at the 180-day follow-up and known risk factors for COVID-19 severity, including male sex, the presence of comorbidities (as listed in Table 1), and serum levels of CRP and S-specific IgG determined at the 60-day follow-up.